OPHTHALMOPATHY
Clinical trials for OPHTHALMOPATHY explained in plain language.
Never miss a new study
Get alerted when new OPHTHALMOPATHY trials appear
Sign up with your email to follow new studies for OPHTHALMOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for thyroid eye disease: drug shows promise in Steroid-Resistant patients
Disease control CompletedThis study looked at whether tocilizumab, a drug that calms the immune system, can help people with active moderate-to-severe thyroid eye disease that did not get better with steroids. Thirty-two adults received the drug every four weeks. Researchers measured improvements in eye …
Matched conditions: OPHTHALMOPATHY
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Severe COVID-19 may leave lasting eye damage
Knowledge-focused CompletedThis study looked at eye damage in 34 people who were hospitalized for severe COVID-19. Researchers used many eye exams and scans to find problems like inflammation, dry eye, and blood vessel damage. The goal was to better understand what eye issues can happen after a serious COV…
Matched conditions: OPHTHALMOPATHY
Phase: NA • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC